Andrea Loewen serves as Executive at REATA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Andrea Loewen has executed 11 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 26, 2023 involved selling 28,416 shares valued at $0.
Andrea Loewen currently holds 28,416 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrea Loewen has been a net seller of RETA stock. They have purchased $0 and sold $2.9M worth of shares.
Andrea Loewen's most recent insider trade was on Sep 26, 2023, when they sold 28,416 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $172.03 |
| Discretionary |
| May 16, 2023 | RETA | $25.4K | Sale | 313 | $81.02 | Discretionary |
| May 15, 2023 | RETA | $8.7K | Sale | 103 | $84.71 | Discretionary |
| May 12, 2023 | RETA | $582.3K | Sale | 6,750 | $86.26 | Discretionary |
| Mar 7, 2023 | RETA | $101.3K | Sale | 1,200 | $84.44 | Discretionary |
| Mar 7, 2023 | RETA | $409.8K | Option Exercise | 15,000 | $27.32 | Discretionary |
| Mar 7, 2023 | RETA | $1.5M | Sale | 17,836 | $83.36 | Discretionary |
| Mar 3, 2023 | RETA | $140.5K | Sale | 1,601 | $87.73 | Discretionary |
| Mar 2, 2023 | RETA | $19.8K | Sale | 218 | $90.61 | Discretionary |
| Jan 3, 2023 | RETA | $0 | Award | 11,756 | $N/A | Discretionary |